S-nitrosothiols: A class of nitric oxide-donor drugs

Clinical Science

Volumn 98, Issue 5, 2000, Pages 507-520

  Al Sa'Doni, Haitham ^a   Ferro, Albert ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Nitric oxide; Nitric oxide donors; S nitrosothiols

Indexed keywords

CARCINOGEN; COPPER ION; CYTOCHROME P450 REDUCTASE; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; S NITROSOTHIOL; SYDNONIMINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANGINA PECTORIS; DRUG DECOMPOSITION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; HYPERTENSION; PHOTODEGRADATION; PRIORITY JOURNAL; REVIEW; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0034095464     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0980507     Document Type: Review

References (92)

1. 1 Culotta, E. and Koshland, Jr., D. E. (1992) NO News is good-news. Science 258, 1862-1865
2. 2 Garthwaite, J. (1991) Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14, 60-67
3. 3 Hibbs, J. B. (1991) Synthesis of nitric oxide from L-arginine - a recently discovered pathway induced by cytokines with antitumor and antimicrobial activity. Res. Immunol. 142, 565-569
4. 4 Marletta, M. A., Yoon, P. S., Iyengar, R., Leaf, C. D. and Wishnok, J. S. (1988) Macrophage oxidation of L-arginine to nitrite and nitrate - nitric oxide is an intermediate. Biochemistry 27, 8706-8711
5. 5 Stuehr, D. J., Gross, S. S., Sakuma, I., Levin, R. and Nathan, C. F. (1989) Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical-reactivity of nitric oxide. J. Exp. Med. 169, 1011-1020
6. 6 Moncada, S., Palmer, R. M. J. and Higgs, E. A. (1991) Nitric oxide - physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142
7. 7 Ignarro, L. J. (1989) Heme-dependent activation of soluble guanylate cyclase by nitric oxide - regulation of enzyme activity by porphyrins and metalloporphyrins. Semin. Hematol. 26, 63-76
8. 8 Ignarro, L. J. (1989) Endothelium-derived nitric-oxide -pharmacology and relationship to the actions of organic nitrate esters. Pharmacol. Res. 6, 651-659
9. 9 Moncada, S., Palmer, R. M. J. and Gryglewski, R. J. (1986) Mechanism of action of some inhibitors of endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A. 83, 9164-9168
10. 10 Moncada, S., Palmer, R. M. J. and Higgs, R. J. (1986) Generation of prostacyclin and endothelium-derived relaxing factor from endothelial cells. In Biology and Pathology of Platelet-Vessel Wall Interactions, pp. 289-304, Academic Press, London
11. 11 Azuma, H., Ishikawa, M. and Sekizaki, S. (1986) Endothelium-dependent inhibition of platelet aggregation. Br. J. Pharmacol. 88, 411-415
12. 12 Furlong, B., Henderson, A. H., Lewis, M. J. and Smith, J. A. (1987) Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br. J. Pharmacol. 90, 687-692
13. 13 Radomski, M. W., Palmer, R. M. J. and Moncada, S. (1987) Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92, 181-187
14. 14 Radomski, M. W., Palmer, R. M. J. and Moncada, S. (1987) The anti-aggregating properties of vascular endothelium -interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92, 636-646
15. 15 Radomski, M. W., Palmer, R. M. J. and Moncada, S. (1987) The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 148, 1482-1489
16. 16 Radomski, M. W., Palmer, R. M. J. and Moncada, S. (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet ii, 1057-1058
17. 17 Butler, A. R. and Williams, D. H. L. (1993) The physiological role of nitric oxide. J. Chem. Soc. Rev. 22, 233-241
18. 18 Feldman, P. L., Griffith, O. W. and Stuehr, D. J. (1993) The surprising life of nitric oxide. Chem. Eng. News 20, 26-38
19. 19 Knowles, R. G. and Moncada, S. (1992) Nitric oxide as a signal in blood-vessels. Trends Biochem. Sci. 17, 399-402
20. 20 Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064
21. 21 Stamler, J. S., Simon, D. I., Osbourne, J. A. et al. (1992) S-Nitrosylation of proteins with nitric oxide - synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U.S.A. 89, 444-448
22. 22 Stamler, J. S., Jaraki, O., Osborne, J. A. et al. (1992) Nitric oxide circulates in mammalian plasma primarily as an S-nitrosoadduct of serum albumin. Proc. Natl. Acad. Sci. U.S.A. 89, 7674-7677
23. 23 Stamler, J. S., Simon, D. I., Jaraki, O. et al. (1992) S-Nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc. Natl. Acad. Sci. U.S.A. 89, 8087-8091
24. 24 Stamler, J. S., Singel, D. J. and Loscalzo, J. (1992) Biochemistry of nitric oxide and its redox-aetivated forms. Science 258, 1898-1902
25. 25 Stamler, J. S. and Loscalzo, J. (1992) Capillary zone electrophoretic detection of biological thiols and their S-nitrosated derivatives. Anal. Chem. 64, 779-785
26. 26 Galla, H. J. (1993) Nitric oxide, NO, an intercellular messenger. Angew Chem. Int. Ed. Engl. 32, 378-380
27. 27 Furchgott, R. F. and Khan, M. T. (1986) Some properties of endothelium-derived relaxing factor (EDRF) released from endothelium cells of rabbit aorta. Fed. Proc. Fed. Am Soc. Exp. Biol. 45, 425
28. 28 Furchgott, R. F. (1988) Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In Mechanisms of Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium, pp. 401-414, Raven Press, New York
29. 29 Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E. and Chaudhuri, G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84, 9265-9269
30. 30 Moncada, S., Radomski, M. W. and Palmer, R. M. J. (1988) Endothelium-derived relaxing factor - identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem. Pharmacol. 37, 2495-2501
31. 31 Abu-Soud, H. M. and Stuehr, J. (1993) Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc. Natl. Acad. Sci. U.S.A. 90, 10769-10772
32. 32 Nathan, C. and Xie, Q. W. (1994) Nitric oxide synthases: roles, tolls and controls. Cell 78, 915-918
33. 33 Mannick, J. B., Asano, K., Izumi, K. et al. (1994) Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79, 1137-1146
34. 34 Geller, D. A., Lowenstein, C. J., Shapiro, R. A. et al. (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 90, 3491-3495
35. 35 Nakane, M., Schmidt, H. H. H. W., Pollock, J. S. et al. (1993) Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 316, 175-180
36. 36 Asano, K., Chee, C., Gaston, B. et al. (1994) Constitutive and inducible nitric oxide synthase gene expression, regulation and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 91, 10089-10093
37. 37 Balligand, J. L., Kobzik, L., Han, X. et al. (1995) Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric-oxide synthase in cardiac myocytes. J. Biol. Chem. 270, 14582-14586
38. 38 Kobzik, L., Reid, M. B., Bredt, D. S. and Stamler, J. S. (1994) Nitric oxide in skeletal muscle. Nature (London) 372, 546-548
39. 39 Shaul, P. W., North, A. J., Wu, L. C. et al. (1994) Endothelial nitric oxide synthase is expressed in cultured human bronchial epithelium. J. Clin. Invest. 94, 2231-2236
40. 40 Snyder, S. (1994) More jobs for that molecule. Nature (London) 372, 504-505
41. 41 Ghafourifar, P. and Richter, C. (1997) Nitric oxide synthase activity in mitochondria. FEBS Lett. 418, 291-296
42. 42 Giulivi, C., Poderoso, J. J. and Boveris, A. (1998) Production of nitric oxide by mitochondria. J. Biol. Chem. 273, 11038-11043
43. 43 Ghafourifar, P. and Richter, C. (1999) Mitochondrial nitric oxide synthase regulates mitochondrial matrix pH. Biol. Chem. Hoppe-Seyler 380, 1025-1028
44. 44 Palmer, R. M. J., Ferrige, A. G. and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 327, 524-526
45. 45 Lipton, S. A. and Stamler, J. S. (1994) Actions of redox-related congeners of nitric oxide at the NMDA receptor. Neuropharmacology 33, 1229-1233
46. 46 Bliss, T. V. and Lomo, T. (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. (London) 232, 331-356
47. 47 Ito, M. (1989) Long-term depression. Annu. Rev. Neurosci. 12, 85-102
48. 48 Dorheim, M. A., Tracey, W. R., Pollock, J. S. and Grammas, P. (1994) Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem. Biophys. Res. Commun. 205, 659-665
49. 49 Koppal, T., Drake, J., Yatin, S. et al. (1999) Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J. Neurochem. 72, 310-317
50. 50 Dawson, V. L. and Dawson, T. M. (1996) Nitric oxide actions in neurochemistry. Neurochem. Int. 29, 97-110
51. 51 Stuehr, D. J. and Marletta, M. A. (1987) Synthesis of nitrite and nitrate in murine macrophage cell-lines. Cancer Res. 47, 5590-5594
52. 52 Hibbs, J. B., Vavrin, Z. and Taintor, R. R. (1987) L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138, 550-565
53. 53 Hibbs, J. B., Taintor, R. R., Vavrin, Z. and Rachlin, E. M. (1988) Nitric oxide - a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157, 87-94
54. 54 Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A. and Freeman, B. A. (1990) Apparent hydroxyl radical production by peroxynitrite - implications for endothelial injury from nitric oxide and Superoxide. Proc. Natl. Acad. Sci. U.S.A. 87, 1620-1624
55. 55 Butler, A. R., Glidewell, C., Hyde, A. R. and Walton, J. C. (1985) Reactions of bis-mu-iodo-bis(dinitrosyliron) with halide ions and with thiols - an electron paramagnetic resonance study. Polyhedron 4, 303-306
56. 56 Drapier, J. C., Pellat, C. and Henry, Y. (1991) Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells co-cultured with activated macrophages. J. Biol. Chem. 266, 10162-10167
57. 57 Salvemini, D., de Nucci, G., Gryglewski, R. J. and Vane, J. R. (1989) Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc. Natl. Acad. Sci. U.S.A. 86, 6328-6332
58. 58 Wink, D. A., Kasprzak, K. S., Maragos, C. M. et al. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254, 1001-1003
59. 59 Bates, J. N., Baker, M. T., Guerra, Jr., R. and Harrison, D. G. (1991) Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem. Pharmacol. 42 (Suppl.), S157-S165
60. 60 Nguyen, T., Brunson, D., Crespi, C. L., Penman, B. W., Wishnok, J. S. and Tannenbaum, S. R. (1992) DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. U.S.A. 89, 3030-3034
61. 61 Butler, A. R., Al-Sa'doni, H. H., Megson, I. L. and Flitney, F. W. (1998) Synthesis, decomposition, and vasodilator action of some new S-nitrosated dipeptides. Nitric Oxide Biol. Chem. 2, 193-202
62. + as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO). J. Chem. Soc. Perkin Trans. 2 4, 481-487
63. 63 Fontecave, M. and Pierre, J. L. (1994) The basic chemistry of nitric oxide and its possible biological reactions. Bull. Soc. Chim. Fr. 131, 620-631
64. 64 Maragos, C. M., Morley, D., Wink, D. A. et al. (1991) Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide - vasorelaxant effects. J. Med. Chem. 34, 3242-3247
65. 65 Maragos, C. M., Wang, J. M., Hrabie, J. A., Oppenheim, J.J. and Keefer, L. K. (1993) Nitric oxide nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res. 53, 564-568
66. 66 Hrabie, J. A., Klose, J. R., Wink, D. A. and Keefer, L. K. (1993) New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 58, 1472-1476
67. 67 Stamler, J. S., Jaraki, O., Osborne, J. et al. (1992) Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. U.S.A. 89, 7674-7677
68. 68 Gaston, B., Sears, S., Woods, J. et al. (1998) Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 351, 1317-1319
69. 69 Clancy, R. M., Levartovsky, D., Leszczynska-Piziak, J., Yegudin, J. and Abramson, S. B. (1994) Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl. Acad. Sci. U.S.A. 91, 3680-3684
70. 70 Gaston, B., Reilly, J., Drazen, J. M. et al. (1993) Endogenous nitrogen-oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. U.S.A. 90, 10957-10961
71. 71 Askew, S. C., Butler, A. R., Flitney, F. W., Kemp, G. D. and Megson, I. (1995) Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione. Bioorg. Med. Chem. 3, 1-9
72. 72 Barnett, D. J., Rios, A. M. and Williams, D. L. H. (1995) Transnitrosation between nitrosothiols and thiols. J. Chem. Soc. Perkin Trans. 2 7, 1279-1282
73. 73 Patel, H. M. S. and Williams, D. L. H. (1990) Nitrosation by alkyl nitrites. 6. Thiolate nitrosation. J. Chem. Soc. Perkin Trans. 2 1, 37-42
74. 74 Barrett, J., Fitygibbones, L. J., Glauser, J., Still, R. H. and Young, P. N. W. (1966) Photochemistry of the S-nitroso derivatives of hexane-1-thiol and hexane-1,6-dithiol. Nature (London) 211, 848
75. 75 Josephy, P. D., Rehorek, D. and Janzen, E. D. (1984) Electron-spin resonance spin trapping of thiyl radicals from the decomposition of thionitrites. Tetrahedron Lett. 25, 1685-1688
76. 76 Mile, B., Rowlands, C. C, Sillaman, P. D. and Fildes, M. (1992) Hyperfine interactions with remote delta-protons in the ESR-spectra of thiyl spin adducts of 5,5-dimethyl-3,4-dihydropyrrole N-oxide (DMPO). J. Chem. Soc. Chem. Commun. 12, 882-883
77. 77 Holmes, A. J. and Williams, D. L. H. (1998) Reactions of S-nitrosothiols with ascorbate: clear evidence of two reactions. Chem. Commun. 16, 1711-1712
78. 78 Megson, I. L., Flitney, F. W., Bates, J. and Webster, R. (1995) Repriming of vascular smooth muscle photorelaxation is dependent upon endothelium-derived nitric oxide. Endothelium 3, 39-46
79. 79 Kowaluk, E. A. and Fung, H.-L. (1990) Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther. 255, 1256-1264
80. 80 Mathews, W. R. and Kerr, S. W. (1993) Biological activity of S-nitrosothiols: the role of nitric oxide. J. Pharmacol. Exp. Ther. 267, 1529-1537
81. 81 Hilliquin, P., Borderie, D., Hernvann, A., Menkes, C.J. and Ekindjian, O. G. (1997) Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum. 40, 1512-1517
82. 82 de Belder, A. J., MacAllister, R., Radomski, M. W., Moncada, S. and Vallance, P. J. (1994) Effects of S-nitrosoglutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc. Res. 28, 691-694
83. 83 Ramsay, B., Radomski, M., de Belder, A., Martin, J. F. and Lopez-Jaramillo, P. (1995) Systemic effects of S-nitrosoglutathione in the human following intravenous infusion. Br. J. Clin. Pharmacol. 40, 101-102
84. 84 Langford, E. J., Brown, A. S., Wainwright, R. J. et al. (1994) Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet 344, 1458-1460
85. 85 Marks, D. S., Vita, J. A., Folts, J. D., Keaney, Jr., J. F., Welch, G. N. and Loscalzo, J. (1995) Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J. Clin. Invest. 96, 2630-2638
86. 86 Roberts, J. M. (1998) Endothelial dysfunction in preeclampsia. Semin. Reprod. Endocrinol. 16, 5-15
87. 87 Lees, C., Langford, E., Brown, A. S. et al. (1996) The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia. Obstet. Gynecol. 88, 14-19
88. 88 Isono, T., Sato, N., Yamamoto, T. et al. (1994) Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409. Eur. J. Pharmacol. 260, 163-168
89. 89 Pizzulli, L., Hagendorff, A., Zirbes, M., Jung, W. and Luderitz, B. (1997) N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function. Am. J. Cardiol. 79, 28-33
90. 90 Chong, S. and Fung, H. L. (1991) Biochemical and pharmacological interactions between nitroglycerin and thiols. Effects of thiol structure on nitric oxide generation and tolerance reversal. Biochem. Pharmacol. 42, 1433-1439
91. 91 Slivka, A., Chuttani, R., Carr-Locke, D. L. et al. (1994) Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans. J. Clin. Invest. 94, 1792-1798
92. 92 Dawson, T. M. and Snyder, S. H. (1994) Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14, 5147-5159